Assessing the impact of antimicrobial resistanceGUMS, John G.American journal of health-system pharmacy. 2002, Vol 59, pp S4-S6, issn 1079-2082, SUP3Conference Paper

Current issues and trends in antimicrobial resistanceGUMS, John G.American journal of health-system pharmacy. 2002, Vol 59, issn 1079-2082, 18 p., SUP3Conference Proceedings

Intranasal Fentanyl Spray: A Novel Dosage Form for the Treatment of Breakthrough Cancer PainDIETRICH, Eric; GUMS, John G.The Annals of pharmacotherapy. 2012, Vol 46, Num 10, pp 1382-1391, issn 1060-0280, 10 p.Article

Ceftobiprole : An Extended-Spectrum Anti-Methicillin-Resistant Staphylococcus aureus CephalosporinANDERSON, Shawn D; GUMS, John G.The Annals of pharmacotherapy. 2008, Vol 42, Num 6, pp 806-816, issn 1060-0280, 11 p.Article

Tezosentan in the treatment of acute heart failureTOVAR, John M; GUMS, John G.The Annals of pharmacotherapy. 2003, Vol 37, Num 12, pp 1877-1883, issn 1060-0280, 7 p.Article

NCCLS perspectives in changing susceptibility breakpoints for antimicrobial drugsGUMS, John G.International journal of antimicrobial agents. 2003, Vol 22, pp S3-S13, issn 0924-8579, SUP1Conference Paper

Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical ConsiderationsCARRIS, Nicholas W; TAYLOR, James R; GUMS, John G et al.Drugs (Basel). 2014, Vol 74, Num 18, pp 2141-2152, issn 0012-6667, 12 p.Article

G Protein Receptor Kinase 4 Polymorphisms β-Blocker Pharmacogenetics and Treatment-Related Outcomes in HypertensionVANDELL, Alexander G; LOBMEYER, Maximilian T; BAILEY, Kent R et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 60, Num 4, pp 957-964, issn 0194-911X, 8 p.Article

Hypertension Susceptibility Loci and Blood Pressure Response to Antihypertensives: Results From the Pharmacogenomic Evaluation of Antihypertensive Responses StudyYAN GONG; MCDONOUGH, Caitrin W; BOERWINKLE, Eric et al.Circulation. Cardiovascular genetics (Print). 2012, Vol 5, Num 6, pp 686-691, issn 1942-325X, 6 p.Article

Genomic Association Analysis of Common Variants Influencing Antihypertensive Response to HydrochlorothiazideTURNER, Stephen T; BOERWINKLE, Eric; PADMANABHAN, Sandosh et al.Hypertension (Dallas, Tex. 1979). 2013, Vol 62, Num 2, pp 391-397, issn 0194-911X, 7 p.Article

Blood Pressure Responses and Metabolic Effects of Hydrochlorothiazide and AtenololSMITH, Steven M; YAN GONG; TURNER, Stephen T et al.American journal of hypertension. 2012, Vol 25, Num 3, pp 359-365, issn 0895-7061, 7 p.Article

Predictors for Glucose Change in Hypertensive Participants Following Short-term Treatment with Atenolol or HydrochlorothiazideMOORE, Mariellen J; YAN GONG; BAILEY, Kent et al.Pharmacotherapy. 2014, Vol 34, Num 11, pp 1132-1140, issn 0277-0008, 9 p.Article

Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive MedicationsCOOPER-DEHOFF, Rhonda M; SHERON WEN; BOERWINKLE, Eric et al.Hypertension (Dallas, Tex. 1979). 2010, Vol 55, Num 1, pp 61-68, issn 0194-911X, 8 p.Article

Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazideDUARTE, Julio D; LOBMEYER, Maximilian T; ZHIYING WANG et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 8, pp 516-519, issn 1744-6872, 4 p.Article